上海协烁仪器科技有限公司
中级会员 | 第6年

13917248560

当前位置:首页   >>   资料下载   >>   Targeting HSP90 dimerization via theC terminus is effective in imatinib-resistant

Targeting HSP90 dimerization via theC terminus is effective in imatinib-resistant

时间:2020-12-23阅读:243
分享:
  • 提供商

    上海协烁仪器科技有限公司
  • 资料大小

    2.3MB
  • 资料图片

  • 下载次数

    0次
  • 资料类型

    PDF 文件
  • 浏览次数

    243次
点击免费下载该资料

Heat shock protein 90 (HSP90) stabilizes many client proteins, including the BCR-ABL1

oncoprotein. BCR-ABL1 is the hallmark of chronic myeloid leukemia (CML) in which
treatment-free remission (TFR) is limited, with clinical and economic consequences. Thus,
there is an urgent need for novel therapeutics that synergize with current treatment
approaches. Several inhibitors targeting the N-terminal domain of HSP90 are under investigation, but side effects such as induction of the heat shock response (HSR) and toxicity
have so far precluded their US Food and Drug Administration approval. We have developed a novel inhibitor (aminoxyrone [AX]) of HSP90 function by targeting HSP90 dimerization via the C-terminal domain.
 

会员登录

×

请输入账号

请输入密码

=

请输验证码

收藏该商铺

X
该信息已收藏!
标签:
保存成功

(空格分隔,最多3个,单个标签最多10个字符)

常用:

提示

X
您的留言已提交成功!我们将在第一时间回复您~
拨打电话
在线留言